Fortitude Family Office’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-93
Closed -$1.14K 1997
2025
Q2
$1.14K Buy
+93
New +$1.17K ﹤0.01% 1448
2025
Q1
Sell
-25
Closed -$398 1159
2024
Q4
$398 Hold
25
﹤0.01% 1232
2024
Q3
$601 Sell
25
-6
-19% -$137 ﹤0.01% 1150
2024
Q2
$618 Buy
+31
New +$604 ﹤0.01% 912

Other funds holding AVNS

Fortitude Family Office's AVNS Position: Q3 2025 in Review

Fortitude Family Office sold out of Avanos Medical (AVNS) in Q3 2025, closing a stake of 93 shares — an estimated $1.14K sold.

Fortitude Family Office first reported a position in AVNS in Q2 2024 and held it in 4 quarters. The position peaked at $1.14K in Q2 2025. 276 funds tracked by Wall St. Rank hold AVNS as of Q3 2025.

  • Fortitude Family Office reported no remaining Avanos Medical position as of Q3 2025 after selling out during the quarter.
  • Fortitude Family Office sold 93 Avanos Medical shares in Q3 2025, an estimated $1.14K.
  • Fortitude Family Office first reported a position in Avanos Medical in Q2 2024 and held it in 4 quarters.
  • Fortitude Family Office's Avanos Medical position peaked at $1.14K in Q2 2025.
  • 276 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2025.

Based on Fortitude Family Office's 13F filing for Q3 2025, filed 17 Oct 2025.